1312593-93-3

Basic information

• Product Name: N-{6-methyl-2-(1H-pyrazol-4-yl)-3-[5-(1-pyrrolidinyl)-3-pyridinyl]thieno[2,3-b]pyridin-4-yl}benzenesulfonamide
• Synonyms: N-{6-methyl-2-(1H-pyrazol-4-yl)-3-[5-(1-pyrrolidinyl)-3-pyridinyl]thieno[2,3-b]pyridin-4-yl}benzenesulfonamide
• CAS NO: 1312593-93-3
• Molecular Weight: 516.648
• Mol File: 1312593-93-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-{6-methyl-2-(1H-pyrazol-4-yl)-3-[5-(1-pyrrolidinyl)-3-pyridinyl]thieno[2,3-b]pyridin-4-yl}benzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-{6-methyl-2-(1H-pyrazol-4-yl)-3-[5-(1-pyrrolidinyl)-3-pyridinyl]thieno[2,3-b]pyridin-4-yl}benzenesulfonamide(1312593-93-3)
• EPA Substance Registry System: N-{6-methyl-2-(1H-pyrazol-4-yl)-3-[5-(1-pyrrolidinyl)-3-pyridinyl]thieno[2,3-b]pyridin-4-yl}benzenesulfonamide(1312593-93-3)

Safety Data

• Hazardous Substances Data: 1312593-93-3(Hazardous Substances Data)

Upstream product

• 1201644-49-6 3-(pyrrolidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine 
• 1312594-99-2 1,1-dimethylethyl 4-{3-bromo-6-methyl-4-[(phenylsulfonyl)amino]thieno[2,3-b]pyridin-2-yl}-1H-pyrazole-1-carboxylate 
• 1312594-98-1 N-[3-bromo-6-methyl-2-(1H-pyrazol-4-yl)thieno[2,3-b]pyridin-4-yl]benzenesulfonamide 
• 1312594-97-0 ethyl 3-bromo-6-methyl-4-[(phenylsulfonyl)amino]-2-(1H-pyrazol-4-yl)thieno[2,3-b]pyridine-5-carboxylate 
• 1312594-95-8 ethyl 6-methyl-4-[(phenylsulfonyl)amino]-2-(1H-pyrazol-4-yl)thieno[2,3-b]pyridine-5-carboxylate 
• 1312594-93-6 ethyl 2-bromo-6-methyl-4-[(phenylsulfonyl)amino]thieno[2,3-b]pyridine-5-carboxylate 
• 1312594-91-4 ethyl 4-amino-2-bromo-6-methylthieno[2,3-b]pyridine-5-carboxylate 
• 1312594-89-0 ethyl 4-amino-6-methylthieno[2,3-b]pyridine-5-carboxylate 
• 944718-19-8 5-bromo-3-(pyrrolidin-1-yl)pyridine 
• 4651-82-5 2-amino-3-cyanothiophene 
• 625-92-3 3,5-dibromopyridine 

Relevant articles and documents

NOVEL COMPOUNDS

The present invention relates to novel NADPH oxidase II inhibitors and their use in the treatment of diseases mediated by the NADPH oxidase II enzyme.